Yutrepia (inhaled treprostinil), an inhaled dry powder formulation of treprostinil for pulmonary arterial hypertension (PAH) and pulmonary…
Articles by Andrea Lobo
Researchers identified two genes — PRDX1 and TNFAIP3 — whose activity levels could serve as diagnostic biomarkers for…
Boosting the levels of irisin, a protein found at lower levels in people with pulmonary arterial hypertension (PAH), may help…
Corvista Health’s machine-learned algorithm can accurately diagnose pulmonary hypertension (PH) in a noninvasive way by assessing the elevation…
Reducing the levels of the protein NEK2 in the pulmonary arteries lessened disease-driving changes in blood vessels and the heart…
Cereno Scientific has completed a type C meeting with the U.S. Food and Drug Administration (FDA) about the design…
The Pulmonary Hypertension Association (PHA) has launched a certificate program to provide advanced practice providers and allied health professionals with specialized…
Pulmonary hypertension (PH) is associated with an increased risk for sleep disorders, including obstructive sleep apnea, and structural brain…
Insulin resistance or IR — a reduced response of body tissues to insulin, a hormone that regulates blood sugar levels…
Tenax Therapeutics said it will extend its Phase 3 clinical development of an oral form of levosimendan for pulmonary…
Winrevair (sotatercept) is generally safe and effective for people with pulmonary arterial hypertension (PAH) when given in addition…
LungFit PH, a device developed by Beyond Air for administering nitric oxide (NO) therapy, has received marketing approval from…